Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial
Transarterial chemoembolization (TACE) represents a first-line noncurative therapy for hepatocellular carcinoma (HCC). Sorafenib, a multikinase inhibitor, has been shown to be effective and safe monotherapy in patients with advanced HCC and the current study reports the interim results of a prospect...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2012
|
| 在线阅读: | https://doi.org/10.1002/ijc.27925 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.27925 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|